29.30

1.31% -0.39

Pre-market: 29.27 -0.03 -0.10%

Janux Therapeutics Inc (JANX)

Overview News Price History Option Chain Financials Discussions Forecast

Janux Therapeutics Inc stock is traded at $29.30, with a volume of 355.15K. It is down -1.31% in the last 24 hours and down -2.14% over the past month. Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Previous Close:

$29.69

Open:

$29.28

24h Volume:

355.15K

Relative Volume:

0.39

Market Cap:

$1.71B

Revenue:

$13.05M

Net Income/Loss:

$-60.54M

P/E Ratio:

-25.26

EPS:

-1.16

Net Cash Flow:

$-37.82M

1W Performance:

+1.21%

1M Performance:

-2.14%

6M Performance:

-41.97%

1Y Performance:

-39.82%

1-Day Range:

$29.04

$30.84

1-Week Range:

$27.93

$30.84

52-Week Range:

$22.52

$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Name

Janux Therapeutics Inc

Sector

Healthcare (1155)

Industry

Biotechnology (677)

Phone

(858) 751-4493

Address

10955 VISTA SORRENTO PARKWAY, SAN DIEGO

Employee

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

JANX's Discussions on Twitter

Compare JANX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JANX Janux Therapeutics Inc	29.30	1.71B	13.05M	-60.54M	-37.82M	-1.16
VRTX Vertex Pharmaceuticals Inc	477.52	127.47B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	561.49	62.43B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	595.70	37.03B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	232.75	31.06B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	229.22	26.16B	3.81B	-644.79M	-669.77M	-6.24

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-24	Reiterated	BTIG Research	Buy
Dec-03-24	Reiterated	H.C. Wainwright	Buy
Nov-22-24	Initiated	Leerink Partners	Outperform
Oct-24-24	Initiated	UBS	Buy
Sep-06-24	Initiated	Stifel	Buy
May-30-24	Initiated	Scotiabank	Sector Perform
Mar-21-24	Initiated	BTIG Research	Buy
Mar-20-24	Initiated	Cantor Fitzgerald	Overweight
Apr-06-23	Initiated	Wedbush	Outperform
Nov-14-22	Initiated	William Blair	Outperform

View All

Janux Therapeutics Inc Stock (JANX) Latest News

Apr 21, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Invesco Ltd. - Defense World

Apr 21, 2025

Apr 17, 2025

Long Term Trading Analysis for (JANX) - news.stocktradersdaily.com

Apr 17, 2025

Apr 16, 2025

Geode Capital Management LLC Boosts Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 16, 2025

Apr 15, 2025

JPMorgan Chase & Co. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 15, 2025

Apr 10, 2025

9,378 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Acquired by Sei Investments Co. - Defense World

Apr 10, 2025

Apr 09, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 09, 2025

Apr 07, 2025

Janux Therapeutics stock hits 52-week low at $23.72 By Investing.com - Investing.com South Africa

Apr 07, 2025

Janux Therapeutics stock hits 52-week low at $23.72 - Investing.com Australia

Apr 07, 2025

Janux Therapeutics: What's My Inflection Point? (NASDAQ:JANX) - Seeking Alpha

Apr 07, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Corebridge Financial Inc. - Defense World

Apr 07, 2025

Apr 05, 2025

Janux Therapeutics: Buying For The Promising Pipeline, Holding For The Buyout (NASDAQ:JANX) - Seeking Alpha

Apr 05, 2025

Apr 01, 2025

(JANX) Investment Report - news.stocktradersdaily.com

Apr 01, 2025

Mar 31, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Teacher Retirement System of Texas - Defense World

Mar 31, 2025

Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 By Investing.com - Investing.com South Africa

Mar 28, 2025

Janux Therapeutics stock hits 52-week low at $28.92 - Investing.com India

Mar 28, 2025

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Insider Monkey

Mar 28, 2025

Mar 26, 2025

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025

Mar 25, 2025